Celgene Reiterated at Buy and 4 Reiterated Ratings to Recognize

Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on September 21st.

Celgene (NASDAQ:CELG): Argus reiterated its rating of Buy for this company and changed its price target from $75 to $88.

Don’t Miss: Analysts Just Love the iPhone 5.

Skyworks (NASDAQ:SWKS): Oppenheimer reiterated its rating of Outperform for this company and changed its price target from $35 to $32.

Approach Resources (NASDAQ:AREX): The Benchmark Company reiterated its rating of Buy for this company and changed its price target from $52 to $50.

Blucora (NASDAQ:BCOR): The Benchmark Company reiterated its rating of Buy for this company and changed its price target from $20 to $23.

Western Asset Mortgage (NYSE:WMC): Wunderlich reiterated its rating of Buy for this company and changed its price target from $22.5 to $24.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>